| RS2070272477 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Neurofibromatosis |
| RS2070273084 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070273520 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2070274228 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070275502 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070287917 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070288287 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070290006 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070290107 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070290843 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070296011 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070298589 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2070298779 |
NF1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS2070299730 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2070315709 |
DLG4
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2070316114 |
DLG4
|
Health Risk |
Pathogenic |
— |
| RS2070316408 |
RAX
|
Health Risk |
Pathogenic |
Isolated microphthalmia 3, Isolated microphthalmia 3 |
| RS2070316606 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2070326034 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070327932 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070327979 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070332383 |
PIGS
|
Health Risk |
Pathogenic |
Glycosylphosphatidylinositol biosynthesis defect 18, Glycosylphosphatidylinositol biosynthesis defect 18 |
| RS2070339252 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070339649 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Juvenile myelomonocytic leukemia, Neurofibromatosis |
| RS2070340004 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070346743 |
G6PD
|
Health Risk |
Pathogenic |
Anemia, nonspherocytic hemolytic |
| RS2070346788 |
G6PD
|
Health Risk |
Likely pathogenic |
Anemia, nonspherocytic hemolytic |
| RS2070350009 |
G6PD
|
Health Risk |
Pathogenic |
G6PD VARNSDORF, Anemia |
| RS2070350038 |
G6PD
|
Health Risk |
Pathogenic |
G6PD ZURICH, Anemia |
| RS2070352108 |
G6PD
|
Health Risk |
Pathogenic |
Anemia, nonspherocytic hemolytic |
| RS2070355916 |
G6PD
|
Health Risk |
Likely pathogenic |
Anemia, nonspherocytic hemolytic |
| RS2070358006 |
G6PD
|
Health Risk |
Conflicting classifications of pathogenicity |
G6PD deficiency, Anemia |
| RS2070372934 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070373881 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070375134 |
G6PD
|
Health Risk |
Conflicting classifications of pathogenicity |
Anemia, nonspherocytic hemolytic |
| RS2070375859 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2070383298 |
G6PD
|
Health Risk |
Likely pathogenic |
Anemia, nonspherocytic hemolytic |
| RS2070395767 |
G6PD
|
Health Risk |
Conflicting classifications of pathogenicity |
G6PD deficiency, Anemia |
| RS2070404146 |
G6PD
|
Health Risk |
Conflicting classifications of pathogenicity |
Anemia, nonspherocytic hemolytic |
| RS2070404412 |
G6PD
|
Health Risk |
Pathogenic |
Anemia, nonspherocytic hemolytic |
| RS2070426 |
PCNT
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2070433656 |
SDCCAG8
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 16, Senior-Loken syndrome 7 |
| RS2070436374 |
COL4A3
|
Health Risk |
Pathogenic |
— |
| RS2070466353 |
TNRC6B
|
Health Risk |
Pathogenic |
— |
| RS2070531732 |
POLR2A
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities, Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities |
| RS2070534871 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive Alport syndrome, Autosomal dominant Alport syndrome |
| RS2070541197 |
TNRC6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Global developmental delay with speech and behavioral abnormalities, Inborn genetic diseases |
| RS2070546216 |
POLR2A
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities, Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities |
| RS2070561031 |
POLR2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe global developmental delay, Severe global developmental delay |
| RS2070581346 |
POLR2A
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities, Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities |
| RS2070588471 |
POLR2A
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities, Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities |
| RS2070591 |
EDNRB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hirschsprung disease, susceptibility to |
| RS2070619300 |
AFF2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2070634 |
AHSG
|
Health Risk |
association |
Nephrolithiasis, calcium oxalate |
| RS2070635 |
AHSG
|
Health Risk |
association |
Nephrolithiasis, calcium oxalate |
| RS2070635297 |
NBEA
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Neurodevelopmental disorder with or without early-onset generalized epilepsy |
| RS2070642658 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2070645772 |
MADD
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with dysmorphic facies, impaired speech |
| RS2070649864 |
TTN
|
Health Risk |
Pathogenic |
Centronuclear myopathy, Dilated cardiomyopathy 1G |
| RS2070665204 |
POLR2A
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities, Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities |
| RS2070680579 |
POLR2A
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities, Inborn genetic diseases |
| RS2070702973 |
G6PD
|
Health Risk |
Likely pathogenic |
Anemia, nonspherocytic hemolytic |
| RS2070706721 |
G6PD
|
Health Risk |
Likely pathogenic |
Anemia, nonspherocytic hemolytic |
| RS2070708365 |
CHKB
|
Health Risk |
Pathogenic |
Megaconial type congenital muscular dystrophy, Megaconial type congenital muscular dystrophy |
| RS2070711917 |
POLR2A
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities, Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities |
| RS2070729548 |
GPC3
|
Health Risk |
Likely pathogenic |
— |
| RS2070732825 |
POLR2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities, Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities |
| RS2070734616 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Alport syndrome, Alport syndrome |
| RS2070736908 |
COL4A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2070773527 |
TRAPPC9
|
Health Risk |
Likely pathogenic |
— |
| RS2070806148 |
IKBKG
|
Health Risk |
Pathogenic |
Immunodeficiency 33, Immunodeficiency 33 |
| RS2070897613 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
COL4A3-related disorder, Autosomal dominant Alport syndrome |
| RS2070901479 |
COL4A3
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2070938396 |
COL4A3
|
Health Risk |
Pathogenic |
— |
| RS2070949441 |
IKBKG
|
Health Risk |
Pathogenic |
Incontinentia pigmenti syndrome, Incontinentia pigmenti syndrome |
| RS2070955 |
FUCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fucosidosis, Fucosidosis |
| RS2070957033 |
NBEA
|
Health Risk |
Pathogenic |
Epilepsy, Neurodevelopmental delay |
| RS2070960570 |
SLC9A6
|
Health Risk |
Conflicting classifications of pathogenicity |
Christianson syndrome, Christianson syndrome |
| RS2070991188 |
SPEN
|
Health Risk |
Likely pathogenic |
Radio-Tartaglia syndrome, Radio-Tartaglia syndrome |
| RS2071009325 |
TNRC6B
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2071044098 |
ACADVL;DLG4
|
Health Risk |
Likely pathogenic |
— |
| RS2071051447 |
DMD
|
Health Risk |
Likely pathogenic |
Becker muscular dystrophy, Duchenne muscular dystrophy |
| RS2071057426 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2071057893 |
CANT1
|
Health Risk |
Pathogenic |
— |
| RS2071059718 |
IKBKG
|
Health Risk |
Pathogenic |
Immunodeficiency 33, Immunodeficiency 33 |
| RS2071063100 |
IKBKG
|
Health Risk |
Pathogenic |
Incontinentia pigmenti syndrome, Incontinentia pigmenti syndrome |
| RS2071063107 |
CANT1
|
Health Risk |
Likely pathogenic |
Abnormality of the skeletal system, Abnormality of the skeletal system |
| RS2071072322 |
GPC3
|
Health Risk |
Likely pathogenic |
Wilms tumor 1, Thyroid cancer |
| RS2071072718 |
GPC3
|
Health Risk |
Pathogenic |
Wilms tumor 1, Wilms tumor 1 |
| RS2071072751 |
GPC3
|
Health Risk |
Pathogenic |
Wilms tumor 1, Wilms tumor 1 |
| RS2071074944 |
GPC3
|
Health Risk |
Likely pathogenic |
Simpson-Golabi-Behmel syndrome type 1, Simpson-Golabi-Behmel syndrome type 1 |
| RS2071085962 |
CANT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Desbuquois dysplasia 1, Desbuquois dysplasia 1 |
| RS2071086256 |
FANCC
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group C, Fanconi anemia complementation group C |
| RS2071086995 |
PCCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2071089000 |
FANCC
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group C, Fanconi anemia complementation group C |
| RS2071101767 |
IKBKG
|
Health Risk |
Pathogenic |
IMMUNODEFICIENCY 33, MALE-RESTRICTED |
| RS2071111529 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS2071119862 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS2071120876 |
IKBKG
|
Health Risk |
Pathogenic |
IKBKG-related disorder, IKBKG-related disorder |
| RS2071121693 |
IKBKG
|
Health Risk |
Pathogenic |
NEMO deleted exon 5-autoinflammatory syndrome (NEMO-NDAS), Autoinflammatory disease |